United States Central Nervous System Agents Market Report 2016

United States Central Nervous System Agents Market Report 2016

1 Central Nervous System Agents Overview

1.1 Product Overview and Scope of Central Nervous System Agents

1.2 Classification of Central Nervous System Agents

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Central Nervous System Agents

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Central Nervous System Agents (2011-2021)

1.4.1 United States Central Nervous System Agents Sales and Growth Rate (2011-2021)

1.4.2 United States Central Nervous System Agents Revenue and Growth Rate (2011-2021)

2 United States Central Nervous System Agents Competition by Manufacturers

2.1 United States Central Nervous System Agents Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Central Nervous System Agents Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Central Nervous System Agents Average Price by Manufactures (2015 and 2016)

2.4 Central Nervous System Agents Market Competitive Situation and Trends

2.4.1 Central Nervous System Agents Market Concentration Rate

2.4.2 Central Nervous System Agents Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Central Nervous System Agents Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Central Nervous System Agents Sales and Market Share by Type (2011-2016)

3.2 United States Central Nervous System Agents Revenue and Market Share by Type (2011-2016)

3.3 United States Central Nervous System Agents Price by Type (2011-2016)

3.4 United States Central Nervous System Agents Sales Growth Rate by Type (2011-2016)

4 United States Central Nervous System Agents Sales (Volume) by Application (2011-2016)

4.1 United States Central Nervous System Agents Sales and Market Share by Application (2011-2016)

4.2 United States Central Nervous System Agents Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Central Nervous System Agents Manufacturers Profiles/Analysis

5.1 Johnson & Johnson

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Central Nervous System Agents Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Johnson & Johnson Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Pfizer

5.2.2 Central Nervous System Agents Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Pfizer Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Novartis

5.3.2 Central Nervous System Agents Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Novartis Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Roche

5.4.2 Central Nervous System Agents Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Roche Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Sanofi

5.5.2 Central Nervous System Agents Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Sanofi Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Merck

5.6.2 Central Nervous System Agents Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Merck Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 GSK

5.7.2 Central Nervous System Agents Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 GSK Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Bayer

5.8.2 Central Nervous System Agents Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Bayer Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Bristol-Myers Squibb

5.9.2 Central Nervous System Agents Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Bristol-Myers Squibb Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 AbbVie

5.10.2 Central Nervous System Agents Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 AbbVie Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Eli Lilly

5.12 AstraZeneca

5.13 Takeda

5.14 Actavis

5.15 Astellas

5.16 Teva

5.17 Biogen

5.18 Shire

6 Central Nervous System Agents Manufacturing Cost Analysis

6.1 Central Nervous System Agents Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Central Nervous System Agents

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Central Nervous System Agents Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Central Nervous System Agents Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Central Nervous System Agents Market Forecast (2016-2021)

10.1 United States Central Nervous System Agents Sales, Revenue Forecast (2016-2021)

10.2 United States Central Nervous System Agents Sales Forecast by Type (2016-2021)

10.3 United States Central Nervous System Agents Sales Forecast by Application (2016-2021)

10.4 Central Nervous System Agents Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Central Nervous System Agents

Table Classification of Central Nervous System Agents

Figure United States Sales Market Share of Central Nervous System Agents by Type in 2015

Table Application of Central Nervous System Agents

Figure United States Sales Market Share of Central Nervous System Agents by Application in 2015

Figure United States Central Nervous System Agents Sales and Growth Rate (2011-2021)

Figure United States Central Nervous System Agents Revenue and Growth Rate (2011-2021)

Table United States Central Nervous System Agents Sales of Key Manufacturers (2015 and 2016)

Table United States Central Nervous System Agents Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Central Nervous System Agents Sales Share by Manufacturers

Figure 2016 Central Nervous System Agents Sales Share by Manufacturers

Table United States Central Nervous System Agents Revenue by Manufacturers (2015 and 2016)

Table United States Central Nervous System Agents Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Central Nervous System Agents Revenue Share by Manufacturers

Table 2016 United States Central Nervous System Agents Revenue Share by Manufacturers

Table United States Market Central Nervous System Agents Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Central Nervous System Agents Average Price of Key Manufacturers in 2015

Figure Central Nervous System Agents Market Share of Top 3 Manufacturers

Figure Central Nervous System Agents Market Share of Top 5 Manufacturers

Table United States Central Nervous System Agents Sales by Type (2011-2016)

Table United States Central Nervous System Agents Sales Share by Type (2011-2016)

Figure United States Central Nervous System Agents Sales Market Share by Type in 2015

Table United States Central Nervous System Agents Revenue and Market Share by Type (2011-2016)

Table United States Central Nervous System Agents Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Central Nervous System Agents by Type (2011-2016)

Table United States Central Nervous System Agents Price by Type (2011-2016)

Figure United States Central Nervous System Agents Sales Growth Rate by Type (2011-2016)

Table United States Central Nervous System Agents Sales by Application (2011-2016)

Table United States Central Nervous System Agents Sales Market Share by Application (2011-2016)

Figure United States Central Nervous System Agents Sales Market Share by Application in 2015

Table United States Central Nervous System Agents Sales Growth Rate by Application (2011-2016)

Figure United States Central Nervous System Agents Sales Growth Rate by Application (2011-2016)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Johnson & Johnson Central Nervous System Agents Sales Market Share (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Central Nervous System Agents Sales Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis Central Nervous System Agents Sales Market Share (2011-2016)

Table Roche Basic Information List

Table Roche Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Table Roche Central Nervous System Agents Sales Market Share (2011-2016)

Table Sanofi Basic Information List

Table Sanofi Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi Central Nervous System Agents Sales Market Share (2011-2016)

Table Merck Basic Information List

Table Merck Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck Central Nervous System Agents Sales Market Share (2011-2016)

Table GSK Basic Information List

Table GSK Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Table GSK Central Nervous System Agents Sales Market Share (2011-2016)

Table Bayer Basic Information List

Table Bayer Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer Central Nervous System Agents Sales Market Share (2011-2016)

Table Bristol-Myers Squibb Basic Information List

Table Bristol-Myers Squibb Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bristol-Myers Squibb Central Nervous System Agents Sales Market Share (2011-2016)

Table AbbVie Basic Information List

Table AbbVie Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Table AbbVie Central Nervous System Agents Sales Market Share (2011-2016)

Table Eli Lilly Basic Information List

Table Eli Lilly Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eli Lilly Central Nervous System Agents Sales Market Share (2011-2016)

Table AstraZeneca Basic Information List

Table AstraZeneca Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Table AstraZeneca Central Nervous System Agents Sales Market Share (2011-2016)

Table Takeda Basic Information List

Table Takeda Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Table Takeda Central Nervous System Agents Sales Market Share (2011-2016)

Table Actavis Basic Information List

Table Actavis Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Table Actavis Central Nervous System Agents Sales Market Share (2011-2016)

Table Astellas Basic Information List

Table Astellas Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Table Astellas Central Nervous System Agents Sales Market Share (2011-2016)

Table Teva Basic Information List

Table Teva Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Table Teva Central Nervous System Agents Sales Market Share (2011-2016)

Table Biogen Basic Information List

Table Biogen Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Table Biogen Central Nervous System Agents Sales Market Share (2011-2016)

Table Shire Basic Information List

Table Shire Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)

Table Shire Central Nervous System Agents Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Central Nervous System Agents

Figure Manufacturing Process Analysis of Central Nervous System Agents

Figure Central Nervous System Agents Industrial Chain Analysis

Table Raw Materials Sources of Central Nervous System Agents Major Manufacturers in 2015

Table Major Buyers of Central Nervous System Agents

Table Distributors/Traders List

Figure United States Central Nervous System Agents Production and Growth Rate Forecast (2016-2021)

Figure United States Central Nervous System Agents Revenue and Growth Rate Forecast (2016-2021)

Table United States Central Nervous System Agents Production Forecast by Type (2016-2021)

Table United States Central Nervous System Agents Consumption Forecast by Application (2016-2021)